F. Magdinier et al., Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region, ONCOGENE, 17(24), 1998, pp. 3169-3176
Germ-line alterations of BRCA1 are responsible for about 50% of familial br
east cancers. Although its biological function(s) has not yet been fully de
termined, it has been suggested that it may act as a tumor suppressor gene
in breast and ovarian cancers. In sporadic breast cancers alterations of BR
CA1 have not been detected and in vitro experiments have indicated that BRC
A1 negatively regulates cellular proliferation, The present study was desig
ned to identify and quantify, the BRCA1 mRNA levels, in normal and neoplasi
c human breast tissue, BRCA1 mRNA molecules were quantified using competiti
ve reverse transcriptase PCR assays. DNA methylation patterns of this gene
have been analysed by Southern blot experiments using methylation sensitive
restriction enzymes. We found that BRCA1 mRNA levels were significantly lo
wer in sporadic breast cancers (37 cases analysed, 24 cases of invasive duc
tal carcinomas not otherwise specified (NOS), two lobular carcinomas in sit
u two medullary carcinomas, four invasive lobular carcinomas, two invasive
mucinous carcinomas and three invasive ductal carcinomas with predominantly
in situ component) compared with normal breast tissues (P = 0.0003), This
down-regulation of BRCA1 is observed in all histologic types analysed. In i
nvasive ductal carcinomas NOS, this down-regulation does not correlate with
any of the prognostic factors studied (tumor size, node status, histologic
grade, hormone receptor status), In the samples analysed, alterations of D
NA methylation patterns were not dectected in the vicinity of the major tra
nscription start site, These data suggest the involvement of BRCA1 in the c
arcinogenesis of these histologic types.